Dyskinesia induced by gabapentin in idiopathic Parkinson's disease.
Raju
Prasanth M
PM
Walker
Richard W
RW
Lee
Mark A
MA
D000368:Aged; D000588:Amines / Q000009:adverse effects* / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D000077206:Gabapentin; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects* / Q000627:therapeutic use
D000588:Amines; D000978:Antiparkinson Agents; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin